Of inquiry directing the President to provide certain documents in the President's possession to the House of Representatives relating to communications by or among any of the Department of Health and Human Services, the Office of National Drug Control Policy, the White House, the Drug Enforcement Administration, and the Department of Justice related to the executive branch's recommendations for a long-term, consensus approach to reduce the supply and availability of illicitly manufactured fentanyl-related substances in the United States.

Summary

Full Text

Legislative Actions

1. 2022-07-26

   Introduced in House

2. 2022-07-26

   Introduced in House

3. 2022-07-26

   Referred to the House Committee on Energy and Commerce.

4. 2022-07-27

   Referred to the Subcommittee on Health.

5. 2022-09-21

   Subcommittee on Health Discharged.

6. 2022-09-21

   Committee Consideration and Mark-up Session Held.

7. 2022-09-21

   Ordered to be Reported Without Recommendation by the Yeas and Nays: 32 - 22.

8. 2022-09-29

   Reported by the Committee on Energy and Commerce. H. Rept. 117-527.

9. 2022-09-29

   Reported by the Committee on Energy and Commerce. H. Rept. 117-527.

10. 2022-09-29

    Placed on the House Calendar, Calendar No. 133.